Abstract
In a 14-year period in a single institution 31 autografts were performed in 26 patients with multiple myeloma (MM), using a simplified and affordable autografting procedure: conducting the grafts on an outpatient basis and avoiding stem cell freezing. Autografts were started on an outpatient basis in all instances, but four patients were admitted to the hospital. Median time to achieve more than 0.5 × 109/l granulocytes was 27 days, whereas median time to recover above 20 × 109/l plts was 37 days. CR was achieved in 19 cases and a very good partial response in 6 cases. The 100-day mortality was 9.6%. The overall median post-transplant survival has not been reached, being above 76 months, whereas the 76-month survival is 80%. The median cost of each procedure was US$ 15 000. Survival results were substantially better than those of historical control in a group of patients treated in the same institution with melphalan/prednisone. It is concluded that high-dose therapy rescued with a simplified autologous stem cell graft is a valid, useful and affordable therapeutic option for patients with MM, even with economical restraints.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Caers Jo, Vandebroek I, De Raeve H, Michaux L, Trullemans F, Schots R et al. Multiple myeloma. An update on diagnosis and treatment. Eur J Haematol 2008; 81: 329–343.
Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21–33.
Ruiz-Delgado GJ, Ruiz-Argüelles GJ . Genetic predisposition for monoclonal gammopathy of undetermined significance. Mayo Clin Proc 2008; 83: 601–603.
Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, Aguilar-Romero L . Multiple myeloma in México: a single institution, twenty-year experience. Arch Med Res 2004; 35: 163–167.
Alexanian R, Dimopoulos M . The treatment of multiple myeloma. N Engl J Med 1994; 330: 484–489.
Vela-Ojeda J, García-Ruiz-Esparza MA, Padilla-González Y, Gómez-Almaguer D, Gutiérrez-Aguirre CH, Gómez-Rangel D et al. Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus IV melphalan. Ann Hematol 2007; 86: 277–282.
Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD . Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood 1988; 71: 723–727.
Ruiz-Argüelles A . Flow cytometry in the clinical laboratory. Principles, applications and problems. Ann Biol Clin 1992; 50: 735–743.
Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412–3420.
Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, Ruiz-Argüelles A, Pérez-Romano B, Rivadeneyra L . Results of an autologous non-cryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single institution, 10-year experience. Acta Haematol 2003; 110: 179–183.
Ruiz-Argüelles GJ . Amoebic paralytic ileus in a patient given an autologous stem cell transplantation. Haema 2006; 9: 431–432.
Mehta J, Singhal S . Current status of autologous hematopoietic stem cell transplantation in myeloma. Bone Marrow Transplant 2008; 42 (Suppl 1): S28–S34.
López-Otero A, Ruiz-Delgado GJ, Ruiz-Argüelles GJ . Es cierto que el trasplante de médula ósea autóloga mejora el pronóstico de los pacientes con mieloma múltiple?: Experiencia de una sola institución en México. Medicina Universitaria 2008; 10: 187–189.
Gertz MA, Ansell SM, Dingli D, Dispenzieri A, Buadi FK, Elliott MA et al. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin Proc 2008; 83: 1131–1138.
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Delgado-Lamas JL . Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol 1998; 58: 161–164.
Ruiz-Argüelles GJ . Outpatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation. Haematologica 2000; 85: 1233–1234.
Gómez-Almaguer D . The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients. Int J Hematol 2002; 76 (Suppl 1): 380–382.
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Larregina-Díez A, Apreza-Molina MG . Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995; 48: 100–103.
Thomas ED . Hematopoietic stem cell transplantation. Sci Am 1995; 272: 38–47.
Gajewski JL, Robinson P . Do affluent societies have the only option for the best therapy? Leukemia 2007; 21: 387–388.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López-Otero, A., Ruiz-Delgado, G. & Ruiz-Argüelles, G. A simplified method for stem cell autografting in multiple myeloma: a single institution experience. Bone Marrow Transplant 44, 715–719 (2009). https://doi.org/10.1038/bmt.2009.71
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.71
Keywords
This article is cited by
-
Lessons Learned Treating Patients with Multiple Myeloma in Resource-Constrained Settings
Current Hematologic Malignancy Reports (2021)
-
Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma
Bone Marrow Transplantation (2018)
-
Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas
Bone Marrow Transplantation (2018)
-
Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward
The Indian Journal of Pediatrics (2017)
-
The Mexican Way: a feasible approach to avoid DMSO toxicity
Bone Marrow Transplantation (2011)